8 patents
Utility
Protein Antigens and Uses Thereof
3 Aug 23
The field of the present invention relates to immunotherapeutic peptides, peptide binding agents, and their use, for example, in the immunotherapy of cancer.
Michael Steven Rooney
Filed: 3 Apr 18
Utility
HLA-based methods and compositions and uses thereof
16 May 23
Compositions and methods for isolating HLA-peptides from cells.
Jennifer Grace Abelin, Rob Carl Oslund, Nir Hacohen, Dominik Barthelme, Michael Rooney
Filed: 22 Nov 19
Utility
T cell manufacturing compositions and methods
2 Nov 21
The generation of antigen specific T cells by controlled ex vivo induction or expansion can provide highly specific and beneficial T cell therapies.
Marit M. Van Buuren, Divya Reddy Lenkala, Joost Huibert Van Den Berg, Jessica Kohler, Matthew Goldstein, Ed Fritsch, Renate De Boer, Ton Schumacher, Noor Bakker
Filed: 6 Jan 20
Utility
Method and Systems for Prediction of Hla Class Ii-specific Epitopes and Characterization of CD4+ T Cells
2 Sep 20
The present disclosure provides method for preparing a personalized cancer vaccine.
Michael Steven Rooney, Jennifer Grace Abelin, Dominik Barthelme, Robert Kamen
Filed: 18 Mar 20
Utility
T Cell Manufacturing Compositions and Methods
27 May 20
The generation of antigen specific T cells by controlled ex vivo induction or expansion can provide highly specific and beneficial T cell therapies.
Marit M. VAN BUUREN, Divya Reddy LENKALA, Joost Huibert VAN DEN BERG, Jessica KOHLER, Matthew GOLDSTEIN, Ed FRITSCH, Renate DE BOER, Ton SCHUMACHER, Noor Bakker
Filed: 5 Jan 20
Utility
Hla-based Methods and Compositions and Uses Thereof
1 Apr 20
The present disclosure provides compositions and methods for isolating HLA-peptides from cells.
Jennifer Grace Abelin, Rob Carl Oslund, Nir Hacohen, Dominik Barthelme, Michael Rooney
Filed: 21 Nov 19
Utility
Hla-based Methods and Compositions and Uses Thereof
25 Mar 20
The present disclosure provides compositions and methods for isolating HLA-peptides from cells.
Jennifer Grace Abelin, Rob Carl Oslund, Nir Hacohen, Dominik Barthelme, Michael Rooney
Filed: 1 Feb 18
Utility
Neoantigens and Methods of Their Use
9 Oct 19
The field of the present invention relates to immunotherapeutic peptides, peptide binding agents, and their use, for example, in the immunotherapy of cancer.
Michael Steven Rooney
Filed: 30 Mar 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first